Psychedelics Business

News

Psychedelics Briefs: Awakn to Study Ketamine Treatment for Gambling Addiction

08/24/2021

Awakn Life Sciences is launching a study on the use of ketamine to treat gambling addiction, while Mydecine and Johns Hopkins have announced plans to collaborate on research of the use of psilocybin for smoking cessation.

Awakn Life Sciences is launching...

08/24/2021

Behavioral Healthcare Executive

News

Psychedelics Briefs: Ketamine One Adds Scent-based VR to Therapy

08/11/2021

Tom Valentino ;

Ketamine One has signed a 2-year agreement for the use of OVR Tech’s Inhale Wellness Platform in its psychedelic-assisted therapies, while Awakn Life Sciences has signed a lease for a new clinic in London.

Ketamine One has signed a 2-year...

08/11/2021

Behavioral Healthcare Executive

News

Psychedelics Briefs: Novamind Opens Utah Clinic, atai Launches Firm to Develop Nose-to-Brain Drug Delivery

08/03/2021

Tom Valentino ;

Novamind has finished construction on a psychedelic-assisted psychotherapy and research center in Utah; atai and UniQuest in Australia have launched a firm to develop nose-to-brain drug delivery method for atai’s medications.

Novamind has finished...

08/03/2021

Behavioral Healthcare Executive

News

Psychedelics Briefs: Field Trip, Cybin Receive Conditional Stock Listing Approvals; Mydecine Applies for Patent

07/27/2021

Tom Valentino ;

Field Trip Health has received conditional approval to list shares on the NASDAQ Global Select Market, and Cybin has received similar approval from the NYSE American stock exchange. Mydecine, meanwhile, has filed for a new patent for...

Field Trip Health has received...

07/27/2021

Behavioral Healthcare Executive

News

Awakn Files Patents for MDMA-Derived Entities to Treat Addiction

07/01/2021

Tom Valentino ;

Awakn Life Sciences Corp has filed patent applications for a pair of novel MDMA-derived new chemical entities for the treatment of alcohol, opioid and behavioral addictions.

Awakn Life Sciences Corp has...

07/01/2021

Behavioral Healthcare Executive

News

Psychedelics Briefs: atai Value Surges in Nasdaq Launch; MindMed Announces CEO Transition

06/23/2021

Tom Valentino ;

atai Life Sciences saw the value of its shares increase by 40% in their first day of trading on the Nasdaq exchange, putting the company’s value at $3.19 billion after its highly anticipated launch on the U.S. stock market. MindMed has...

atai Life Sciences saw the value...

06/23/2021

Behavioral Healthcare Executive

News

Ketamine One Announces Virtual Reality R&D Program

06/09/2021

Tom Valentino ;

Ketamine One has announced that its MindScape facility in Houston has launched a research and development program to study the use of immersive virtual reality to enhance patients’ ketamine-assisted treatments, as well as ongoing development...

Ketamine One has announced that...

06/09/2021

Behavioral Healthcare Executive

News

Delic Acquires Ketamine Infusion Centers

06/08/2021

Tom Valentino ;

Psychedelic wellness platform Delic Holdings has acquired Ketamine Infusion Centers, which operates ketamine infusion treatment clinics in Phoenix and Bakersfield, California. The

Psychedelic wellness platform...

06/08/2021

Behavioral Healthcare Executive

News

Novamind Projects 225% Increase in Clinic Visits for 2021

06/02/2021

Novamind, a mental health company that specializes in psychedelic medicine, this week announced revenues of $1.85 million for its fiscal quarter ending March 31, a 43% increase over the prior quarter.

Novamind, a mental health...

06/02/2021

Behavioral Healthcare Executive

Braxia Health Becomes First Ketamine Therapy Provider in Quebec

05/14/2021

Braxia Scientific, a Canadian operator of outpatient psychedelic research and treatment facilities, announced it has entered into a joint venture with Neurotherapy Montreal to open the first ketamine therapy clinic in Quebec.

Braxia Scientific, a Canadian...

05/14/2021

Behavioral Healthcare Executive

Browse Our Other Brands

Psychedelics Business

Browse Our Other Brands

Specialties

Events

Year Round Education

HMP Global Products